Background {#Sec1}
==========

Hospital readmission adversely affects patients and healthcare systems. The rate of hospital readmission is an important problem faced by the Japanese health care system. Readmission may occur because of unresolved acute illness, ongoing chronic illness, the development of new medical complications, or from gaps in outpatient care \[[@CR1], [@CR2]\]. In the post-intensive care setting, early hospital readmission is an indicator of poor-quality care of these vulnerable patients. Indeed, patients admitted to intensive care units (ICUs) who survive to hospital discharge have a higher 6-month mortality rate post-discharge than patients hospitalized without critical illness. In addition, they experience significant morbidity subsequent to their ICU stay \[[@CR3], [@CR4]\].

Unplanned hospital readmission is a more informative marker of clinical deterioration than all-cause hospital readmission since planned readmissions do not indicate poor-quality care \[[@CR5], [@CR6]\]. Only one study assessed predictors associated with readmission of critically ill patients using claims data \[[@CR2]\]. In that study, admissions scheduled at least 24 h in advance were considered operationally planned admissions and were not included in the definition of re-hospitalization; hence, this definition might have underestimated the true prevalence of readmission.

Identifying predictors associated with unplanned hospital readmission may inform policymakers and facilitate identification of high-risk patients to be targeted for future interventions. However, such data are currently lacking in Japan. Therefore, the aim of this study was to determine the predictors associated with unplanned hospital readmission of ICU survivors within 30 days of hospital discharge by using routine admissions data from the Japanese Diagnosis Procedure Combination (DPC) database. In addition, because we hypothesized that medical and surgical patients would have different predictors for readmission, we analyzed medical and surgical patients separately.

Methods {#Sec2}
=======

Data source {#Sec3}
-----------

The Tokyo Medical and Dental University ethics committee approved this study and waived the requirement for informed consent. The DPC database is a Japanese case-mix classification system linked to a payment system. Details of the DPC have been described elsewhere \[[@CR7], [@CR8]\]. In short, by 2011, data from more than 1400 acute care hospitals were included in the DPC database, covering approximately 50% of patients discharged from all Japanese hospitals. The database includes data on baseline patient information; diagnosis, according to the International Classification of Diseases and Injuries, 10th revision (ICD-10); medical procedures; medications; materials; discharge destination; and information regarding hospital readmission.

Study population {#Sec4}
----------------

Data of all patients admitted to ICU between April 2012 and February 2014 who survived to hospital discharge were retrospectively extracted from the DPC database using ICU bed utilization billing codes. Patients who required only step-down unit care (high care unit care) were not included. Exclusion criteria were as follows: missing data on admission, admission dates, or discharge dates; age less than 18 years; and hospital length of stay (LOS) \> 365 days. Data of patients who were readmitted to other hospitals were unavailable because patient registration numbers differ at each hospital.

Data collection and classification {#Sec5}
----------------------------------

We divided the hospital readmission cohort into medical and surgical cases. Patients who underwent any surgery were considered surgical cases. All other patients were considered medical cases. The cause, type (planned or unplanned), and outcome of hospital readmission were obtained from the DPC database. Planned hospital readmissions were not counted as re-hospitalization events in this analysis because we were interested in investigating hospital readmissions that are potentially preventable. Subsequent hospital readmissions were counted if they met the inclusion criteria.

We used the Charlson comorbidity index (CCI) to quantify the burden of comorbid illness \[[@CR9]\]. Level of consciousness was assessed at admission using the Japan Coma Scale score: 0 (alert), 1--3 (delirious), 10--30 (somnolent), and 100--300 (comatose) \[[@CR10]\]. The category of primary diagnosis of each patient was defined using ICD-10 coding, as presented in Additional file [1](#MOESM1){ref-type="media"}: Table S1. The categories considered were cardiac, respiratory, neurologic, gastrointestinal, malignancy, metabolic and renal, and other. Hospital-level characteristics, academic status (teaching or non-teaching), and size (\< 399, 400--799, and \> 800 beds) were captured. Hospital LOS was categorized into four groups: 1--15, 16--30, 31--45, and \> 46 days.

Data on the use of a vasopressor, stress ulcer prophylaxis, blood products (packed red blood cells \[pRBC\], fresh frozen plasma \[FFP\], and platelets), low-dose steroids, total parental nutrition (TPN), any antibiotic, renal replacement therapy (RRT), and ventilation were extracted from the DPC database.

Outcomes {#Sec6}
--------

The primary outcome was unplanned hospital readmission within 30 days of discharge following the index hospitalization. Unplanned readmission rates for the medical and surgical cohorts were calculated by dividing the number of survivors readmitted by the total number of survivors in each cohort. Diagnosis on hospital readmission was categorized using primary ICD-10 diagnosis categories.

Statistical analysis {#Sec7}
--------------------

Data were presented as means ± standard deviation, medians and interquartile ranges (IQR), or percentages, as appropriate. Length of ICU stay was calculated based on the number of days billed. We used multivariable logistic regression to identify predictors associated with 30-day unplanned hospital readmission. The results were presented as odds ratios and 95% confidence intervals. We examined the following co-variables: teaching hospital; hospital size; age; sex; CCI score; category of primary diagnosis; coma on admission; hospital LOS; discharge destination; and requirement for vasopressors, stress ulcer prophylaxis, blood product (pRBC, FFP, platelet) transfusion, steroids, anticoagulant therapy, TPN, antibiotics, RRT, ventilation, and tracheostomy. Multicollinearity between covariates was assessed using variance inflation factor and tolerance values. To assess the model performance, we calculated the area under the receiver operating characteristic curve. The curves measured the model's ability to distinguish between readmission and no readmission by evaluating the C-statistic. A C-statistic equals to one indicates perfect discrimination, whereas a C-statistic of 0.5 indicate that the ability of the model to discriminate is due to chance. All analyses were performed using R statistical software, version 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria).

Results {#Sec8}
=======

Characteristics of survivors {#Sec9}
----------------------------

We enrolled 559,240 patients from 502 hospitals who were admitted to ICU for at least 1 day between April 2012 and February 2014. Overall hospital mortality was 9.1% (medical, 18.1% and surgical, 6.5%). After excluding patients for the reasons outlined in Fig. [1](#Fig1){ref-type="fig"}, the final cohort included 486,651 ICU patients who survived to hospital discharge. The 30-day unplanned hospital readmission rates following medical and surgical admissions were 3.8% (5583 of 147,423) and 3.3% (11,142 of 339,228), respectively. In the medical group, 5102 (3.6%) of all unique patients admitted were readmitted once, 383 (0.3%) were readmitted twice, and 77 (0.1%) were readmitted three times or more. In the surgical group, 10,573 (3.2%) of all unique patients admitted were readmitted once, 520 (0.2%) were readmitted twice, 45 (0.01%) were readmitted three times or more.Fig. 1Selection of adult survivors of medical and surgical intensive care unit admission

The characteristics of the cohorts of medical and surgical survivors are shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. The mean age of patients was 69.7 ± 14.4 years for the medical cohort and 68.2 ± 14.3 years for the surgical cohort. The median ICU stay was 2 (IQR, 1--4) days for medical and 1 (IQR, 1--3) day for surgical cases, and the median length of hospital stay was 17 (IQR, 10--32) days for medical and 22 (IQR, 15--37) days for surgical cases. Medical patients were discharged home (76.3%), transferred to another hospital (20.6%), or discharged to a skilled nursing facility (2.2%). On the other hand, 84.5% of surgical patients were discharged home, 13.9% were transferred to another hospital, and 0.8% were discharged to a skilled nursing facility.Table 1Baseline characteristics of survivors in medical and surgical intensive care unitsCharacteristicMedicalSurgicalNo unplanned readmissionUnplanned readmissionNo unplanned readmissionUnplanned readmission(*n* = 141,840)(*n* = 5583)(*n* = 328,086)(*n* = 11,142)Hospital characteristics Teaching, *n* (%)23,329 (17.2)794 (14.9)100,516 (31.9)2840 (26.6) Size, *n* (%) \< 399 beds49,826 (36.7)2012 (37.7)74,587 (23.7)2654 (24.9) 400--799 beds62,135 (45.8)2568 (48.1)154,905 (49.2)5575 (52.2) \> 800 beds23,715 (17.5)759 (14.2)85,576 (27.2)2451 (22.9)Age, mean (SD), year69.7 (14.4)70.1 (14.2)68.2 (14.3)68.7 (14.2)Men, *n* (%)89,565 (63.1)3450 (61.8)193,766 (59.1)7109 (63.8)BMI, mean (SD)22.9 (4.4)22.2 (4.2)22.7 (4.3)22.4 (4.0)CCI, median (IQR)1 (0--2)1 (0--2)1 (0--2)1 (0--2) 0, *n* (%)52,063 (36.7)1686 (30.2)137,257 (41.8)3836 (34.4) 1, *n* (%)45,830 (32.3)1683 (30.1)87,625 (26.7)3040 (27.3) 2, *n* (%)26,809 (18.9)1251 (22.4)56,597 (17.3)2146 (19.3) ≥ 3, *n* (%)17,138 (12.1)963 (17.2)46,607 (14.2)2120 (19.0)Primary category of diagnosis on admission *n* (%) Cardiac69,882 (49.3)2792 (50.0)49,981 (15.2)1807 (16.2) Respiratory8626 (6.1)549 (9.8)5853 (1.8)257 (2.3) Neurologic31,903 (22.5)799 (14.3)61,290 (18.7)1822 (16.4) Gastrointestinal4336 (3.1)252 (4.5)25,473 (7.8)1180 (10.6) Malignancy7158 (5.0)330 (5.9)138,309 (42.2)4645 (41.7) Metabolic and renal5055 (3.6)297 (5.3)6507 (2.0)329 (3.0) Other14,880 (10.5)564 (10.1)40,673 (12.4)1102 (9.9)Coma on admission, *n* (%)8697 (6.1)285 (5.1)6157 (1.9)198 (1.8)ICU stay, median (IQR), days2 (1--4)2 (1--5)1 (1--3)1 (1--3)Hospital stay, median (IQR), days18 (10--32)21 (12--37)22 (15--37)26 (17--44) 1--15 days, *n* (%)62,371 (44.0)1936 (34.7)93,430 (28.5)2364 (21.2) 16--30 days, *n* (%)41,160 (29.0)1823 (32.7)125,972 (38.4)4125 (37.0) 31--45 days, *n* (%)16,266 (11.5)783 (14.0)49,191 (15.0)1994 (17.9) \> 45 days, *n* (%)22,043 (15.5)1041 (18.6)59,493 (18.1)2659 (23.9)Discharge destination Home, *n* (%)107,590 (75.9)4572 (81.9)276,386 (84.2)9821 (88.1) Other hospital, *n* (%)29,937 (21.1)698 (12.5)46,441 (14.2)1072 (9.6) Skilled nursing facility, *n* (%)3099 (2.2)230 (4.1)2458 (0.7)154 (1.4) Other, *n* (%)1214 (0.9)83 (1.5)2800 (0.9)95 (0.9)*SD* standard deviation, *BMI* body mass index, *CCI* Charlson comorbidity index, *IQR* interquartile range, *ICU* intensive care unitTable 2Treatments received in medical and surgical intensive care units during hospitalizationCharacteristicMedicalSurgicalNo unplanned readmissionUnplanned readmissionNo unplanned readmissionUnplanned readmission(*n* = 141,840)(*n* = 5583)(*n* = 328,086)(*n* = 11,142)Vasopressor, *n* (%)26,513 (18.7)1136 (20.3)93,209 (28.4)3319 (29.8)Stress ulcer prophylaxis, *n* (%)107,214 (75.6)4266 (76.4)256,934 (78.3)9277 (83.3)Blood product usagepRBC, *n* (%)15,930 (11.2)891 (16.0)109,216 (33.3)4937 (44.3) FFP, *n* (%)2563 (1.8)147 (2.6)23,040 (7.0)1006 (9.0) Platelets, *n* (%)4050 (2.9)224 (4.0)33,954 (10.3)1468 (13.2)Steroid use, *n* (%)5812 (4.1)303 (5.4)20,556 (6.3)838 (7.5)Anticoagulant therapy, *n* (%)86,280 (60.8)3296 (59.0)232,864 (71.0)8163 (73.3)TPN, *n* (%)36,037 (25.4)1574 (28.2)130,747 (39.9)4998 (44.9)Antibiotic usage, *n* (%)64,532 (45.5)2972 (53.2)269,500 (82.1)9399 (84.4)RRT Number, *n* (%)9722 (6.9)609 (10.9)19,073 (5.8)998 (9.0) Duration, days, median (IQR)3 (2--6)3 (2--5)4 (2--6)3 (2--6)VentilationNumber, *n* (%)27,731 (19.6)1459 (26.1)82,005 (25.0)3395 (30.5) Duration, days, median (IQR)4 (2--9)4 (2--8)2 (1--6)2 (1--6)Tracheostomy *n* (%)2626 (1.9)91 (1.6)8978 (2.7)295 (2.6)*pRBC* packed red blood cells, *FFP* fresh frozen plasma, *TPN* total parental nutrition, *RRT* renal replacement therapy, *IQR* interquartile range

During the index hospitalization, the proportions of medical and surgical cases, respectively, requiring various treatments were as follows: vasopressors, 27 vs 43%; stress ulcer prophylaxis, 76 vs 78%; pRBCs, 11 vs 33%; low-dose steroids, 4 vs 7%. Ventilation was required for a median of 4 (2--9) days for medical and 2 (1--6) days for surgical patients, and 7% of medical and 6% of surgical patients received RRT.

Timing of and reasons for unplanned hospital readmission {#Sec10}
--------------------------------------------------------

The majority of 30-day unplanned hospital readmissions occurred within 15 days of initial hospital discharge; 60.9% of the medical and 63.1% of the surgical readmissions occurred within 15 days, while 32% of readmissions in each cohort occurred within the first 7 days of discharge (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). The most common categories of diagnosis assigned to ICU survivors at the time of unplanned hospital readmission were cardiac (31.5%) for medical cases and malignancy (19.6%) for surgical cases (Table [3](#Tab3){ref-type="table"}). The in-hospital mortality rate was 10.5% for medical and 7.5% for surgical ICU survivors who were rehospitalized.Table 3Reasons for and outcomes of 30-day unplanned hospital readmissions of ICU survivorsCategory of primary diagnosis, *n* (%)MedicalSurgicalAt readmissionAt initial index admissionAt admissionAt initial index admission(*n* = 5583)(*n* = 147,423)(*n* = 11,142)(*n* = 339,228) Cardiac1758 (31.5)72,674 (49.3)1298 (11.6)51,788 (15.3) Malignancy345 (6.2)7488 (5.1)2184 (19.6)14,2954 (42.1) Respiratory738 (13.2)9175 (6.2)1138 (10.2)6110 (1.8) Neurologic636 (11.4)32,702 (22.2)1022 (9.2)63,112 (18.6) Gastrointestinal640 (11.5)4588 (3.1)1298 (11.6)26,653 (7.9) Metabolic and renal575 (10.3)5352 (3.6)991 (8.9)6836 (2.0)Other891 (16.0)15,444 (10.5)2457 (22.1)41,775 (12.3)Outcomes Hospital length of stay, median (IQR)15 (8--28)14 (8--26) Hospital mortality, %585 (10.5)836 (7.5)*ICU* intensive care unit, *IQR* interquartile range

Predictors associated with 30-day unplanned hospital readmission {#Sec11}
----------------------------------------------------------------

In the multivariable logistic regression analysis, the factors associated with increased 30-day unplanned hospital readmission rate were similar for medical and surgical patients (Table [4](#Tab4){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Table S2). The area under the receiver operating characteristic curve was 0.64 (0.63--0.65) for the medical patients and 0.62 (0.61--0.63) for the surgical patients (Additional file [3](#MOESM3){ref-type="media"}: Figure S2).Table 4Predictors associated with 30-day unplanned hospital readmission of ICU survivorsMedicalSurgical(*n* = 147,840)(*n* = 339,228)VariableOR (95% CI)OR (95% CI)Teaching hospital--0.79 (0.75--0.84)Hospital size \< 399 bedsReferenceReference 400--799 beds0.98 (0.93--1.05)0.99 (0.94--1.04) \> 800 beds0.77 (0.69--0.87)0.90 (0.84--0.97)CCI1.10 (1.08--1.12)1.05 (1.04--1.06)Category of primary admission diagnosis CardiacReferenceReference Respiratory1.30 (1.17--1.45)1.51 (1.31--1.75) Neurologic0.64 (0.58--0.70)1.02 (0.95--1.09) Gastrointestinal1.18 (1.02--1.36)1.59 (1.46--1.73) Malignancy0.85 (0.75--0.97)1.18 (1.10--1.26) Metabolic and renal1.25 (1.10--1.43)1.58 (1.38--1.79) Other0.93 (0.84--1.03)0.99 (0.91--1.08)Coma on admission0.87 (0.76--0.99)Hospital length of stay 1--15 daysReferenceReference 16--30 days1.44 (1.34--1.54)1.21 (1.14--1.27) 31--45 days1.62 (1.47--1.78)1.43 (1.34--1.53) \> 45 days1.58 (1.43--1.75)1.56 (1.46--1.68)Discharge destination HomeReferenceReference Other hospital0.48 (1.47--1.78)0.53 (0.50--0.57) Skilled nursing facility1.46 (1.26--1.69)1.46 (1.23--1.73) Others1.38 (1.02--1.65)0.88 (0.70--1.08)Stress ulcer prophylaxis--1.22 (1.15--1.29)pRBC infusion1.16 (1.05--1.28)1.43 (1.37--1.51)Low-dose steroid1.14 (1.01--1.29)1.08 (1.00--1.16)Anticoagulation0.81 (0.76--0.87)--TPN--1.05 (1.00--1.09)Antibiotics1.09 (1.02--1.17)--RRT1.28 (1.15--1.41)1.24 (1.15--1.34)Ventilation1.18 (1.09--1.27)--Tracheostomy--0.83 (0.74--0.95)*ICU* intensive care unit, *OR* odds ratio, *CI* confidence interval, *CCI* Charlson comorbidity index, *pRBC* packed red blood cells, *FFP* fresh frozen plasma, *TPN* total parental nutrition, *RRT* renal replacement therapy

Discussion {#Sec12}
==========

In a large database of acute care hospitals in Japan, the key findings show that the overall cumulative 30-day unplanned hospital readmission rate following ICU admission was 3.4% (medical cases, 3.8%; surgical cases, 3.3%). For both medical and surgical patients, CCI; category of primary diagnosis (respiratory, gastrointestinal, and metabolic and renal); hospital LOS; discharge destination (skilled nursing facility); and receipt of pRBC transfusion, low-dose steroids, or RRT were associated with higher rates of unplanned hospital readmission.

Hospital readmission has become a major concern, especially in the realm of critical care medicine, as hospital readmissions affect patient quality of life, morbidity, and mortality \[[@CR2], [@CR4], [@CR11], [@CR12]\]. In addition, Krumholz and others \[[@CR1], [@CR13]\] proposed the idea of a post-hospital syndrome, namely, that patients become vulnerable to new health impairments for a transient period following hospitalization as a result of physical and cognitive disability, nutritional impairment, sleep deprivation, and continued delirium that increases their susceptibility to further illness post-discharge. While the spectrum of readmission diagnoses is largely diverse, respiratory infection, heart failure, digestive disorders, and renal disorders are common reasons for readmission \[[@CR1], [@CR14]\]. In fact, our findings showed that the proportions of respiratory, gastrointestinal, and metabolic and renal reasons for ICU admission were higher for readmission than for initial admission. Critically ill survivors of recent hospitalization are more vulnerable \[[@CR15]\] and have a higher risk of unplanned hospital readmission \[[@CR2]\]. Therefore, appropriate methods to identify patients at higher risk of readmission are essential to improve quality of care after discharge.

We found that the cumulative prevalence proportion of 30-day unplanned hospital readmission (3.6%) was similar to the reported proportion of heart failure in the DPC database \[[@CR16]\]. On the other hand, a recent study using an administrative database in New York State revealed that the cumulative incidence of early unplanned rehospitalization within 30 days of discharge for survivors of critical illness was 16.2% \[[@CR2]\]. Among all acute care, nonfederal hospitals in California, the all-cause 30-day readmission rates were 20.4, 23.6, and 17.7% for sepsis, congestive heart failure, and acute myocardial infarction, respectively \[[@CR17]\]. Our results suggest that there is a discrepancy between re-hospitalization rates in Japan and the USA. Several possible factors, such as the Japanese social context, the universal health care system, and the demographics of the cohort, may explain why critically ill survivors in Japan showed lower rehospitalization rates than those in the USA. Notably, hospital LOS would be an important reason. Patients in Japan are generally hospitalized for longer periods than patients in the USA \[[@CR18]\]; the LOS in Japan was twice as long as in the USA in one report \[[@CR19]\]. In Japan, general wards are often used to provide rehabilitation and nursing care in addition to acute medical care for prolonged periods \[[@CR16]\]. This practice might mitigate post-hospital syndrome and reduce gaps in outpatient care. Furthermore, we included patients under 60 years old; this group has the lowest rate of hospital readmission \[[@CR2]\]. These factors contributed to the lower unplanned hospital readmission rates observed in Japan in the present study.

To examine the difference between medical and surgical cases, we divided ICU survivors into two groups; the rate of hospital readmission for surgical cases was lower than for medical cases. On the other hand, Hua et al. showed that non-surgical and surgical ICU survivors had the same cumulative rehospitalization rate (16.5% for non-surgical vs 15.9% for surgical; *P* = .87) \[[@CR2]\]. Unlike hospital readmission of medical patients, readmission of surgical patients often results from delayed recognition of surgical procedure complications \[[@CR20], [@CR21]\]. Thus, the shorter the hospital LOS in general, the greater the possibility that complications will be identified after discharge. However, early medical follow-up of patients who are discharged after a surgical procedure is often performed in Japan \[[@CR22]\], leading to lower rates of unplanned hospital readmission \[[@CR5]\].

We identified several predictors associated with increased 30-day unplanned hospital readmission. Longer hospital LOS and discharge to skilled nursing facilities were identified as predictors in other studies assessing early rehospitalization \[[@CR2], [@CR5], [@CR23]--[@CR25]\]. Longer hospital LOS during the initial hospitalization is indicative of a more critically ill patient or the development of postoperative complications that might lead to rehospitalization \[[@CR2], [@CR5], [@CR24], [@CR26]\]. Additionally, past research has suggested that hospital readmission of patients discharged to skilled nursing facilities is higher than that of patients discharged to other destinations \[[@CR23], [@CR27]\]. A significant variation exists in the quality of care across skilled nursing facilities in Japan \[[@CR28]\] and there is a paucity of reported data about care metrics. Better inpatient care, more complete predischarge resolution of certain problems, more effective care transitions to the home/community setting, and closer follow-up after discharge are important ways to reduce hospital readmissions.

Measures to prevent re-hospitalization remain elusive, as Walraven et al. in a recent systematic review reported that only 27% of hospital readmissions were preventable \[[@CR29]\]. While most of predictors for hospital readmission in the present study can be considered as markers of severity of illness, RBC transfusion, which is possibly associated with increased risk of nosocomial infection, acute lung injury and acute kidney injury, \[[@CR30]\] will be a potential target for intervention to reduce readmission rate. Future studies will be required to confirm this hypothesis.

Strengths and limitations {#Sec13}
-------------------------

There are several strengths to our study. First, we were able to investigate 30-day unplanned hospital readmissions in a large nationwide cohort of ICU survivors in Japan. As planned hospital readmissions do not reflect poor-quality care \[[@CR5], [@CR31], [@CR32]\], we analyzed only unplanned hospital readmission as the primary outcome in this study. Second, adult patients of all ages were available in the DPC database, which accounted for whole adult ICU population. Third, the outcomes of and reasons for patients being readmitted to hospital were evaluated. This allowed us to identify the timing of hospital readmission and to evaluate the mortality associated with these hospital readmissions in the 30 days after discharge following the index hospitalization.

The present study also has several limitations. First, as our data source was an administrative database, we do not have information regarding patients who were readmitted to other hospitals, or information regarding out-of-hospital deaths. Also, we were not able to link data among patients transferred to another hospital. Hence, the true readmission rate may have been underestimated. However, death within 30 days post-discharge is a rare event \[[@CR31]\]. Second, because our data were from Japan, our findings may not be generalizable to other countries with different healthcare systems, although some predictors such as longer index hospitalization, and discharge to a skilled nursing in the present study were also identified in other studies in other countries \[[@CR2], [@CR33], [@CR34]\]. Third, data on some of the potential predictors, such as laboratory data, functional status, degree of social support, and adherence to medical treatment, were unavailable. Furthermore, our risk adjustment may have been limited due to the lack of general severity scoring models (Acute Physiology and Chronic Health Evaluation, Simplified Acute Physiology Score, or Sequential Organ Failure Assessment score), although we used treatments and procedures during the ICU stay as the surrogate measure. Fourth, information of end-of-life decisions to limit life-sustaining therapies was not available in our data, which could affect clinicians' decisions not to readmit those patients. Fifth, information with regards to ICU and hospital discharge policy (senior decision or not, criteria, contribution of social workers, or relation with the family members) was unavailable. Finally, data on quality of care by medical professionals in the ICU that contributed to the care of each patient were lacking.

Conclusion {#Sec14}
==========

In a large national database in Japan, the prevalence proportion of unplanned rehospitalization within 30 days of hospital discharge following ICU admission was 3.4%. We also found that critically ill patients with a higher CCI score; whose initial category of primary diagnosis was respiratory, gastrointestinal, or metabolic and renal; who had a longer hospital LOS; who were discharged to a skilled nursing facility; or who required pRBC infusion, low-dose steroids, or RRT during the index admission had a higher risk of 30-day unplanned hospital readmission. Further studies are required to improve readmission prediction modeling and targeted interventions for high-risk patients.
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